Global Ischemic Heart Disease (IHD) Drugs Market Set to Expand, Projected Value of $7.9 Billion by 2028
September 21, 2023 09:58 ET
|
Research and Markets
Dublin, Sept. 21, 2023 (GLOBE NEWSWIRE) -- The "Ischemic Heart Disease Drugs Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028" report has been added to ...
Specialty Clinics Emerge as Key End-Users in the Global Angina Pectoris Drugs Market 2023-2030
September 20, 2023 06:23 ET
|
Research and Markets
Dublin, Sept. 20, 2023 (GLOBE NEWSWIRE) -- The "Global Angina Pectoris Drugs Market by Type, Drugs, Route of Administration, End-Users - Cumulative Impact of COVID-19, Russia Ukraine Conflict, and...
Global Antihypertensive Drugs Market Outlook 2023-2030 by Therapy, Type of Drug, and Region
July 26, 2023 05:08 ET
|
Research and Markets
Dublin, July 26, 2023 (GLOBE NEWSWIRE) -- The Global Antihypertensive Drugs Market Outlook 2023-2030 report has been added to ResearchAndMarkets.com's offering. The Global Antihypertensive Drugs...
Global Nephrology Drugs Market Projected to Garner a Revenue of $21,454.5 Million and Rise at a CAGR of 6.0% during the Forecast Period 2021-2028 [170-Pages] | Exclusive by Research Dive
February 06, 2023 09:01 ET
|
Research Dive
New York, USA, Feb. 06, 2023 (GLOBE NEWSWIRE) -- According to a report published by Research Dive, the global nephrology drugs market is anticipated to generate a revenue of $21,454.5 million and...
Outlook on the Angina Pectoris Treatment Global Market to 2030 - by Drug Class and Region
January 31, 2023 09:28 ET
|
Research and Markets
Dublin, Jan. 31, 2023 (GLOBE NEWSWIRE) -- The "Angina Pectoris Treatment Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and...
Insights on the Pulmonary Arterial Hypertension Global Market to 2027 - Advanced Oral Drugs for Pulmonary Arterial Hypertension Presents Opportunities
January 26, 2022 06:13 ET
|
Research and Markets
Dublin, Jan. 26, 2022 (GLOBE NEWSWIRE) -- The "Global Pulmonary Arterial Hypertension (2021-2027) by Drug Class, Route of Administration, Distribution Mode, and Geography, IGR Competitive Analysis,...
China Nifedipine Market Investigation Report 2021-2025
December 31, 2021 05:23 ET
|
Research and Markets
Dublin, Dec. 31, 2021 (GLOBE NEWSWIRE) -- The "Investigation Report on China's Nifedipine Market 2021-2025" report has been added to ResearchAndMarkets.com's offering. According to the analyst's...
Worldwide Pulmonary Arterial Hypertension Industry to 2026 - Advance Oral Drugs for Pulmonary Arterial Hypertension Present Opportunities
July 05, 2021 04:28 ET
|
Research and Markets
Dublin, July 05, 2021 (GLOBE NEWSWIRE) -- The "Global Pulmonary Arterial Hypertension Market (2021-2026) by Drug Class, Route of Administration, Distribution Mode, Geography, Competitive Analysis...
Worldwide Pulmonary Arterial Hypertension Industry to 2025 - Featuring Gilead Sciences, United Therapeutics and Novartis International Among Others
January 20, 2021 06:33 ET
|
Research and Markets
Dublin, Jan. 20, 2021 (GLOBE NEWSWIRE) -- The "Global Pulmonary Arterial Hypertension (2020-2025) by Drug Class, Route of Administration, Distribution Mode, Geography, Competitive Analysis and the...
Global Pulmonary Arterial Hypertension (PAH) Drugs Market Report 2020: Increasing Awareness Regarding Available Treatment Alternatives to Drive Market Growth
December 01, 2020 05:18 ET
|
Research and Markets
Dublin, Dec. 01, 2020 (GLOBE NEWSWIRE) -- The "Pulmonary Arterial Hypertension (PAH) Drugs Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2020-2025" report has been...